CERUMENEX Drug Patent Profile
✉ Email this page to a colleague
When do Cerumenex patents expire, and what generic alternatives are available?
Cerumenex is a drug marketed by Pharm Res Assoc and is included in one NDA.
The generic ingredient in CERUMENEX is trolamine polypeptide oleate condensate. There is one drug master file entry for this compound. Additional details are available on the trolamine polypeptide oleate condensate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for CERUMENEX?
- What are the global sales for CERUMENEX?
- What is Average Wholesale Price for CERUMENEX?
Summary for CERUMENEX
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 90 |
| Patent Applications: | 4,018 |
| DailyMed Link: | CERUMENEX at DailyMed |
US Patents and Regulatory Information for CERUMENEX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharm Res Assoc | CERUMENEX | trolamine polypeptide oleate condensate | SOLUTION/DROPS;OTIC | 011340-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
